Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and ROS signalingChunmei Xiu, Jianquan Chen, Xi Luo et al.|Metabolism|2025Cited by 15
Suppression of non-muscle myosin II boosts T cell cytotoxicity against tumorsYingyun Yang, Yuying Liu, Dahan Wen et al.|Science Advances|2024Cited by 7